Low-Level Viremia in Hepatitis B Patients on Antiviral Treatment: Can We Ignore It?

被引：3
作者：
Min, Albert D. [1 ]
机构：
[1] Icahn Sch Med Mt Sinai, Div Digest Dis, Mt Sinai Beth Israel, 10 Union Sq East,2G, New York, NY 10003 USA
来源：
HEPATOLOGY | 2017年 / 66卷 / 02期
关键词：
HEPATOCELLULAR-CARCINOMA; ENTECAVIR TREATMENT; CIRRHOSIS; RISK;
D O I：
10.1002/hep.29235
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：312 / 314
页数：3
相关论文
共 11 条
  • [1] Lower Observed Hepatocellular Carcinoma Incidence in Chronic Hepatitis B Patients Treated With Entecavir: Results of the ENUMERATE Study
    Ahn, Joseph
    Lim, Joseph K.
    Lee, Hannah M.
    Lok, Anna S.
    Mindie Nguyen
    Pan, Calvin Q.
    Mannalithara, Ajitha
    Te, Helen
    Reddy, K. Rajender
    Huy Trinh
    Chu, Danny
    Tram Tran
    Lau, Daryl
    Leduc, Truong-Sinh
    Min, Albert
    Loc Trong Le
    Bae, Ho
    Sang Van Tran
    Do, Son
    Hann, Hie-Won L.
    Wong, Clifford
    Han, Steven
    Pillai, Anjana
    Park, James S.
    Tong, Myron
    Scaglione, Steve
    Woog, Jocelyn
    Kim, W. Ray
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 (09) : 1297 - 1304
  • [2] Entecavir Treatment for up to 5 Years in Patients with Hepatitis B e Antigen-Positive Chronic Hepatitis B
    Chang, Ting-Tsung
    Lai, Ching-Lung
    Yoon, Seung Kew
    Lee, Samuel S.
    Coelho, Henrique Sergio M.
    Carrilho, Flair Jose
    Poordad, Fred
    Halota, Waldemar
    Horsmans, Yves
    Tsai, Naoky
    Zhang, Hui
    Tenney, Daniel J.
    Tamez, Ricardo
    Iloeje, Uchenna
    [J]. HEPATOLOGY, 2010, 51 (02) : 422 - 430
  • [3] Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level
    Chen, CJ
    Yang, HI
    Su, J
    Jen, CL
    You, SL
    Lu, SN
    Huang, GT
    Iloeje, UH
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 295 (01): : 65 - 73
  • [4] Kim HS, 2016, HEPATOLOGY, V64, p38A
  • [5] Low-Level Viremia and the Increased Risk of Hepatocellular Carcinoma in Patients Receiving Entecavir Treatment
    Kim, Jung Hee
    Sinn, Dong Hyun
    Kang, Wonseok
    Gwak, Geum-Youn
    Paik, Yong-Han
    Choi, Moon Seok
    Lee, Joon Hyeok
    Koh, Kwang Cheol
    Paik, Seung Woon
    [J]. HEPATOLOGY, 2017, 66 (02) : 335 - 343
  • [6] Antiviral therapy for chronic hepatitis B viral infection in adults: A systematic review and meta-analysis
    Lok, Anna S. F.
    McMahon, Brian J.
    Brown, Robert S., Jr.
    Wong, John B.
    Ahmed, Ahmed T.
    Farah, Wigdan
    Almasri, Jehad
    Alahdab, Fares
    Benkhadra, Khalid
    Mouchli, Mohamed A.
    Singh, Siddharth
    Mohamed, Essa A.
    Abu Dabrh, Abd Moain
    Prokop, Larry J.
    Wang, Zhen
    Murad, Mohammad Hassan
    Mohammed, Khaled
    [J]. HEPATOLOGY, 2016, 63 (01) : 284 - 306
  • [7] Hepatitis B Surface Antigen Loss: Not All That We Hoped It Would Be
    Nathanson, Michael H.
    Terrault, Norah
    [J]. HEPATOLOGY, 2016, 64 (02) : 328 - 329
  • [8] Hepatocellular carcinoma risk in chronic hepatitis B virus-infected compensated cirrhosis patients with low viral load
    Sinn, Dong Hyun
    Lee, Junggyu
    Goo, Juna
    Kim, Kyunga
    Gwak, Geum-Youn
    Paik, Yong-Han
    Choi, Moon Seok
    Lee, Joon Hyeok
    Koh, Kwang Cheol
    Yoo, Byung Chul
    Paik, Seung Woon
    [J]. HEPATOLOGY, 2015, 62 (03) : 694 - 701
  • [9] AASLD guidelines for treatment of chronic hepatitis B
    Terrault, Norah A.
    Bzowej, Natalie H.
    Chang, Kyong-Mi
    Hwang, Jessica P.
    Jonas, Maureen M.
    Murad, M. Hassan
    [J]. HEPATOLOGY, 2016, 63 (01) : 261 - 283
  • [10] Cirrhosis Is Present in Most Patients With Hepatitis B and Hepatocellular Carcinoma
    Yang, Ju Dong
    Kim, W. Ray
    Coelho, Ritika
    Mettler, Teresa A.
    Benson, Joanne T.
    Sanderson, Schuyler O.
    Therneau, Terry M.
    Kim, Bohyun
    Roberts, Lewis R.
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2011, 9 (01) : 64 - 70
12